Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

Wen, Wen; Chen, Chen; Tang, Jiake; Wang, Chunyi; Zhou, Mengyun; Cheng, Yongran; Zhou, Xiang; Wu, Qi; Zhang, Xingwei; Feng, Zhanhui; Wang, Mingwei; Mao, Qin

doi:10.1080/07853890.2022.2034936

Public

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis

Published in Annals of Medicine • Feb 4, 2022

Authors:

Wen Wen

Chen Chen

Jiake Tang

Abstract

BACKGROUND: The coronavirus disease (COVID-19) epidemic has not been completely controlled. Although great achievements have been made in COVID-19 research and many antiviral drugs have shown good therapeutic effects against COVID-19, a simple oral antiviral drug for COVID-19 has not yet been develo...

Subject

Medicine

Adverse effect

Odds ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!